A remarkable response to Sacubitril/Valsartan in severe cardiomyopathy secondary to cardiotoxic chemotherapy.

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Cases: Chronic Heart Failure and Comorbidities Cardio-Oncology HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by